wine

From Aaushi
Jump to navigation Jump to search

Introduction

Contains small amounts of sulfite. also see red wine

Indications

* only slow ethanol metabolizers benefit[1]

Adverse effects

Laboratory

More general terms

More specific terms

References

  1. Jump up to: 1.0 1.1 1.2 Gepner Y et al Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med. Published online 13 October 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26458258 <Internet> http://annals.org/article.aspx?articleid=2456121
  2. Jump up to: 2.0 2.1 2.2 American Association for Cancer Research. Dec 1, 2016 Alcohol Intake Associated with Increased Risk of Melanoma. http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=967#.WFRg1ZLF4fp
    Rivera A, Nan H, Li T, Qureshi A, Cho E. Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States. Cancer Epidemiology, Biomarkers & Prevention. Dec 2016 http://cebp.aacrjournals.org/content/25/12/1550
  3. Jump up to: 3.0 3.1 Hydes TJ, Burton R, Inskip H. A comparison of gender-linked population cancer risks between alcohol and tobacco: how many cigarettes are there in a bottle of wine? BMC Public Health. 2019, 19:316, March 28 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30917803 Free full text https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-6576-9
  4. Jump up to: 4.0 4.1 4.2 Lou N Cardiovascular Protection Tracks With Wine Intake, Now Provable With Urinary Marker. Biomarker of wine consumption believed to reduce misclassification and bias in study. MedPage Today December 18, 2024. https://www.medpagetoday.com/cardiology/prevention/113456
    Dominguez-Lopez I, Lamuela-Raventos RM, Razquin C et al Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial. Eur Heart J. 2024 Dec 18:ehae804. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39689849 https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehae804/7920812